Humana Inc.
HUM Healthcare Healthcare Plans
Humana Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.7 billion, up 10.1% from fiscal 2024. In the quarter to June 2026, revenue grew 26.2%, EPS grew 27.9%, free cash flow grew 58.5% and total debt rose 13.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
Follow HUM
Humana Inc. (HUM) P/B ratio
As of 16 October 2026, Humana Inc. (HUM) trades at a P/B ratio of 2.6×. Over the past ten years it has ranged from 1.1× (March 2026) to 4.6× (November 2018); the current reading is higher than 28% of that period. That is in line with the Healthcare Plans industry median of 2.6× and above the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 1.7× | (6.49%) |
| FY2024 | 1.9× | (47.87%) |
| FY2023 | 3.6× | (13.32%) |
| FY2022 | 4.1× | 11.05% |
| FY2021 | 3.7× | (6.17%) |
| FY2020 | 4.0× | (3.21%) |
| FY2019 | 4.1× | 5.30% |
| FY2018 | 3.9× | 4.92% |
| FY2017 | 3.7× | 33.73% |
| FY2016 | 2.8× | 7.13% |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Jun 2026 | 2.5× | 121.10% |
| Mar 2026 | 1.1× | (35.67%) |
| Dec 2025 | 1.7× | 3.29% |
| Sep 2025 | 1.7× | 4.54% |
| 42 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| CVS CVS Health Corporation compare | 1.5× |
| CNC Centene Corporation compare | 1.5× |
| CI Cigna Group compare | 1.9× |
| ELV Elevance Health, Inc. compare | 2.1× |
| MOH Molina Healthcare, Inc compare | 2.5× |
| HUM Humana Inc. | 2.6× |
| UNH UnitedHealth Group Incorporated compare | 3.5× |
| OSCR Oscar Health, Inc. compare | 4.7× |
| CLOV Clover Health Investments, Corp. compare | 6.2× |
| Healthcare Plans industry median | 2.6× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on HUM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement